BioHarvest Sciences (BHST) to Release Earnings on Monday

BioHarvest Sciences (NASDAQ:BHST) is expected to post its quarterly earnings results before the market opens on Monday, March 31st. Analysts expect BioHarvest Sciences to post earnings of ($0.12) per share and revenue of $7.24 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

BioHarvest Sciences Stock Performance

BioHarvest Sciences stock opened at $6.21 on Monday. The firm has a market capitalization of $102.00 million, a price-to-earnings ratio of -4.97 and a beta of 2.27. BioHarvest Sciences has a 52 week low of $6.04 and a 52 week high of $7.63. The business’s 50-day moving average is $5.58.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. HC Wainwright assumed coverage on BioHarvest Sciences in a report on Friday, December 6th. They set a “buy” rating and a $14.00 target price on the stock. Maxim Group began coverage on BioHarvest Sciences in a report on Wednesday, December 18th. They issued a “buy” rating and a $12.00 price objective on the stock.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.